Terms: = Pancreatic cancer AND UBR5, EDD, 51366, ENSG00000104517, EDD1, KIAA0896, HYD, MGC57263, DD5, O95071, FLJ11310 AND Diagnosis
2 results:
1. E3 ubiquitin ligase ubr5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract] [Full Text] [Related]
2. [SCLEROUSIS CHOLANGITIS AT THE AUTOIMMUNE PANCREATITIS PATIENT].
Gavrilina NS; Sedova GA; Kosyura SD; Fedorov IG; Ilchenko LY; Storozhakov G
Eksp Klin Gastroenterol; 2015; (7):78-84. PubMed ID: 26817126
[TBL] [Abstract] [Full Text] [Related]